The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection

Table 1 Clinical outcome of macaques infected intravaginally with R5 SHIV _SF162P3N

Clinical status	Animal	Challenge dose; frequency	Time to necropsy (weeks)
Transient Viremic	AH94	10,000; 2X	54
	DE37	10,000; 2X	59
Chronic progressor	CG45	1,000; 1X	59
	CG63	1,000; 1X	59
	FR25	10,000; 1X	129
	FV44	10,000; 1X	53
	GH62	10,000; 1X	53
	GR56	10,000; 1X	53
	CF18	10,000; 2X	52*
	FH84	10,000; 2X	104*
Rapid progressor	DG17	1,000; 1X	22*
	GC70	1,000; 1X	24*
	EI77	10,000; 1X	27*
	EL48	10,000; 1X	17*

ISSN: 1742-4690